BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 11067914)

  • 1. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognate B cell signaling via MHC class II: differential regulation of B cell antigen receptor and MHC class II/Ig-alpha beta signaling by CD22.
    Mills DM; Stolpa JC; Cambier JC
    J Immunol; 2004 Jan; 172(1):195-201. PubMed ID: 14688326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
    J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1.
    Otipoby KL; Draves KE; Clark EA
    J Biol Chem; 2001 Nov; 276(47):44315-22. PubMed ID: 11551923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
    Sato S; Jansen PJ; Tedder TF
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
    Fujimoto M; Poe JC; Hasegawa M; Tedder TF
    J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
    Ochi H; Watanabe T
    Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
    Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
    J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
    Chan VW; Lowell CA; DeFranco AL
    Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22.
    Yohannan J; Wienands J; Coggeshall KM; Justement LB
    J Biol Chem; 1999 Jun; 274(26):18769-76. PubMed ID: 10373493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop.
    Fujimoto M; Bradney AP; Poe JC; Steeber DA; Tedder TF
    Immunity; 1999 Aug; 11(2):191-200. PubMed ID: 10485654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.
    Hokazono Y; Adachi T; Wabl M; Tada N; Amagasa T; Tsubata T
    J Immunol; 2003 Aug; 171(4):1835-43. PubMed ID: 12902484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor modulators of B-cell receptor signalling--CD19/CD22.
    Smith KG; Fearon DT
    Curr Top Microbiol Immunol; 2000; 245(1):195-212. PubMed ID: 10533314
    [No Abstract]   [Full Text] [Related]  

  • 15. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
    Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
    J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
    Poe JC; Hasegawa M; Tedder TF
    Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD19 signaling pathways play a major role for murine AIDS induction and progression.
    Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
    J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
    Greer SF; Justement LB
    J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin.
    Tooze RM; Doody GM; Fearon DT
    Immunity; 1997 Jul; 7(1):59-67. PubMed ID: 9252120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.